z-logo
open-access-imgOpen Access
Genotypic and allelic frequencies of MDR1 gene in dogs in Italy
Author(s) -
Marelli Stefano Paolo,
Polli Michele,
Frattini Stefano,
Cortellari Matteo,
Rizzi Rita,
Crepaldi Paola
Publication year - 2020
Publication title -
veterinary record open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.504
H-Index - 12
eISSN - 2052-6113
pISSN - 2399-2050
DOI - 10.1136/vetreco-2019-000375
Subject(s) - allele , genotype , biology , genetics , veterinary medicine , breed , crossbreed , allele frequency , gene , medicine
Background A mutation in the canine multidrug resistance MDR1 gene (also referred as ABCB1 ), encoding for the multidrug resistance ( MDR ) P‐glycoprotein (P‐gp) transponder, causes a pathological condition known as ‘ivermectin toxicosis’. The causative mutation, known since 2001, has been described to affects sheep herding breeds related to collie lineage. The present study is a retrospective investigation of the presence of MDR1 mutated allele in Italian dog populations in a 5 years’ time lapse. The aim of the research is to offer a deep knowledge in MDR1 allelic and genotypic frequencies in canine breeds and populations raised in Italy. Methods Genotype data for the 4‐bp deletion (c296_299del4) in MDR1 gene from 811 dogs belonging to 32 breeds/populations were collected. Results The mutated allele has been found in 9 out of 31 breeds: Rough Collie, Smooth Collie, Border Collie, Bearded Collie, Shetland Sheepdog, Australian Shepherd, White Swiss Shepherd, Old English Sheepdog, Whippet and also in crossbreed. The breeds with the highest allelic mutation frequency are Smooth and Rough Collies with 75 per cent and 66 per cent of mutant MDR1 allele, respectively. Conclusions The results support the usefulness of this genetic analysis to optimise medical care in dogs at risk of multidrug resistance and to create an objective basis in breeding programme definition and in the risk evaluation in different breeds.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here